Published in J Gen Virol on November 01, 1982
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81
Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78
Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A (1996) 3.54
A human cell factor is essential for HIV-1 Rev action. EMBO J (1990) 2.43
Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21
Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol (1998) 2.09
High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol (1997) 2.07
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol (1994) 1.83
The budding mechanism of spikeless vesicular stomatitis virus particles. EMBO J (1986) 1.81
Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J Virol (1994) 1.75
Lipid rafts and pseudotyping. J Virol (2001) 1.75
Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein. J Virol (1992) 1.45
Cell surface influenza haemagglutinin can mediate infection by other animal viruses. EMBO J (1985) 1.35
Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles. J Virol (1992) 1.28
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein. J Virol (1998) 1.26
Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein. J Virol (1999) 1.25
Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J Virol (2009) 1.09
Phenotypic mixing of rodent but not avian hepadnavirus surface proteins into human hepatitis B virus particles. J Virol (1995) 1.04
Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res Hum Retroviruses (2011) 1.01
Minimal exclusion of plasma membrane proteins during retroviral envelope formation. Proc Natl Acad Sci U S A (2000) 1.01
Packaging cells for avian leukosis virus-based vectors with various host ranges. J Virol (1992) 1.00
Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus. J Virol (1989) 0.98
Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. J Virol (1998) 0.90
The roles of lipids and nucleic acids in HIV-1 assembly. Front Microbiol (2014) 0.89
Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging. J Virol (2000) 0.86
Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol (1998) 0.83
Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization. J Virol (2012) 0.82
Pseudotypes of vesicular stomatitis virus with CD4 formed by clustering of membrane microdomains during budding. J Virol (2005) 0.82
Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions. J Virol (2012) 0.81
Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles. Retrovirology (2014) 0.77
A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice. PLoS One (2014) 0.77
In Vivo Analysis of Infectivity, Fusogenicity, and Incorporation of a Mutagenic Viral Glycoprotein Library Reveals Determinants for Virus Incorporation. J Virol (2016) 0.75
Pseudotypes of vesicular stomatitis virus with the coat of murine leukaemia and of avian myeloblastosis viruses. J Gen Virol (1972) 2.82
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
A novel quasi-viral agent, MaTu, is a two-component system. Virology (1992) 2.22
Human cell surface proteins selectively assembled into vesicular stomatitis virus virions. Virology (1983) 1.74
Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol (1994) 1.69
VSV pseudotype particles with the coat of avian myeloblastosis virus. Nat New Biol (1972) 1.49
Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. Acta Virol (1972) 1.30
Viral pseudotypes and phenotypic mixing. Arch Virol (1976) 1.26
Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus. Virology (1977) 1.21
Complementation and phenotypic stabilization of vesicular stomatitis virus temperature-sensitive and thermolabile mutants by avian myeloblastosis virus. Intervirology (1974) 1.04
Assembly of xenotropic murine leukaemia virus-related antigens from the surface of mouse L cells by vesicular stomatitis virus. Acta Virol (1983) 0.92
Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease. Physiol Res (2003) 0.84
Pseudotype particles of vesicular stomatitis virus with surface antigens of bovine leukaemia virus--VSV (BLV) -- as a sensitive probe for detecting antibodies in the sera of spontaneously infected cattle. Acta Virol (1978) 0.82
Further characterization of proteins assembled by vesicular stomatitis virus from human tumor cells. Virology (1984) 0.80
VSV pseudotype produced in cell line derived from human mammary carcinoma. Nat New Biol (1972) 0.80
A rapid neutralization test for antibodies to bovine leukemia virus, with the use of rhabdovirus pseudotypes. J Natl Cancer Inst (1979) 0.79
Identification of MaTu-MX agent as a new strain of lymphocytic choriomeningitis virus (LCMV) and serological indication of horizontal spread of LCMV in human population. Virology (1999) 0.79
Cross-neutralization between vesicular stomatitis virus type Indiana and Chandipura virus. Acta Virol (1979) 0.78
A host-cell DNA function involved in the replication of avian tumour viruses and of fowl-plague virus. J Gen Virol (1969) 0.78
Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations. Acta Virol (1980) 0.76
General approach to the synthesis of persubstituted hydrophilic and amphiphilic beta-cyclodextrin derivatives. J Org Chem (2001) 0.76
Host-cell repair of ultraviolet-irradiated pseudorabies virus in chick embryo cells. Acta Virol (1968) 0.76
Rescue of presumptive viral information from human cells by a helper oncovirus. J Gen Virol (1986) 0.76
An apparently two-factor dose-response dependence in lucerne mosaic virus assay. Acta Virol (1967) 0.75
A transmissible antigen detected in two cell lines derived from human tumours. J Gen Virol (1974) 0.75
[Establishment of specific antigen in human embryonal cells (author's transl)]. Bratisl Lek Listy (1980) 0.75
Attempts to induce immunological tolerance to Western equine encephalomyelitis virus. Acta Virol (1966) 0.75
Attempt to influence viral mouse leukaemia by simultaneous infection with influenza A1 virus. Biomedicine (1973) 0.75
The interfering activity of phage lysates. Folia Microbiol (Praha) (1966) 0.75
Comparison of radioimmunoassay for internal protein of bovine leukemia virus with neutralization test employing VSV-BLV pseudotype. Neoplasma (1980) 0.75
Diagnostics of enzootic leukosis in cattle in Czechoslovakia and the methods of its suppression. Ann Rech Vet (1978) 0.75
Phenotypic mixing of vesicular stomatitis virus (VSV) with vaccinia virus. Acta Virol (1982) 0.75
[Benefits and risks of urologic laparoscopic surgery in adult patients]. Rozhl Chir (2003) 0.75
Vesicular stomatitis virus phenotypically mixed with retroviruses: an efficient detection method. Acta Virol (1983) 0.75
Double neutralization of fowl plague virus reproduced in chick myeloblasts. Acta Virol (1968) 0.75
MaTu--a contaminant or an anti-cancer vaccine? Folia Biol (Praha) (1993) 0.75
Monoclonal antibody against an antigen selectively assembled into vesicular stomatitis virus virions from HeLa cells. Int J Cancer (1984) 0.75
[A double penetration wound of the thoracic wall in an Afghan military policeman]. Rozhl Chir (2009) 0.75